REG - Competition and Mkts - Merger Update : Eurofins / Cellmark

Eurofins Scientific SEAnnouncement

02/08/2024 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240802:nRSB8232Ya&default-theme=true

RNS Number : 8232Y  Competition and Markets Authority  02 August 2024

 

Merger Clearance: Anticipated acquisition by Eurofins Forensics Lux Holding
Sarl (Eurofins) of DNACO Limited (Cellmark)

The CMA has decided, on the information currently available to it, not to
refer the above merger to a phase 2 investigation under the provisions of the
Enterprise Act 2002:

The text of this decision will be placed on the dedicated case page
(https://www.gov.uk/cma-cases/eurofins-slash-cellmark-merger-inquiry) as soon
as is reasonably practicable.

In the event of media enquiries please email press@cma.gov.uk
(mailto:Press@cma.gov.uk)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MERBGGDIBXGDGSB